A psychiatrist who advises the state of Minnesota on which drugs to use in Medicaid programs received $488,953 in speaking fees from Indianapolis-based Eli Lilly and Co. over eight years through 2006, according to an Associated Press analysis. The fees, received by John E. Simon, have raised questions about whether Simon was influenced to recommend […]
Eli Lilly and Co.’s depression drug Cymbalta dampened pain in patients with fibromyalgia and has asked the Food and Drug Administration to approve it for secondary use, the Indianapolis pharmaceutical maker said today. Patients experienced less pain beginning a week after taking the treatment, a study showed. Two percent to 4 percent of Americans, mostly […]
In the less than two years since Mark Miles, 53, took over the CEO-driven Central Indiana Corporate Partnership in 2006, he’s
transformed it into an economic development powerhouse for life sciences, information technology and advanced manufacturing.
How so fast? He started networking with Indiana’s political heavyweights more than 30 years ago. And he never stopped.
Downtown and suburban vacancy rates are declining slightly or at least holding steady-a positive sign for an Indianapolis office market absorbing a plethora of new space on the city’s north side. The second-quarter vacancy rate for the central business district dropped to 15.9 percent, from 16.7 percent the previous quarter, according to data from the local office of St. Louis-based commercial real estate firm Colliers Turley Martin Tucker. A similar report from the local office of Los Angeles-based CB Richard…
Local hospitality firm’s early work with Lilly helped it carve out a major niche in the pharmaceutical market.
To make money on new software, sometimes you have to give it away. Thanks to that counterintuitive approach, tiny local IT startup Vyante Inc. has persuaded companies like Eli Lilly and Co., Roche Diagnostics, Dow Agro-Sciences and 5MetaCom to test the beta version of its new software, which tracks and measures the impact of their brands online. Vyante hopes eventually to convert the companies into paying customers. “We’ve persisted against the odds,” said Vyante Senior Technologist Benjamin Ranck. “It was…
Eli Lilly and Co. could face the juicy prospect of a $2 billion hole in the diabetes market if the Food and Drug Administration acts on a recommendation from one of its safety scientists. David Graham is set to tell FDA advisers today to pull diabetes pill Avandia from the U.S. market, according to Bloomberg. […]
Emotions in the Seattle area are still raw months after Indianapolis-based Eli Lilly and Co. bought full ownership of Icos Corp. and promptly announced that it would wipe out most of Icos’ 700 jobs. Lilly acquired the Bothel, Wash., maker of the Cialis erectile dysfunction drug for $2.3 billion in December. The massive job loss […]
A development team including locally based Prince/Alexander Architects has filed plans to build a 24-story tower between Eli Lilly & Co.’s Faris Campus and Lucas Oil Stadium. The $47-million project calls…
A Food and Drug Administration advisory panel has recommended approving Eli Lilly and Co.’s Evista osteoporosis drug for cutting the risk of cancer in post-menopausal women with osteoporosis and post-menopausal women at high risk for breast cancer. The non-binding recommendation follows an announcement from Lilly earlier this month that Evista reduced the risk of certain […]
Investors embraced Eli Lilly and Co. stock this morning after the company’s second-quarter profit beat analysts’ expectations. Shares of the Indianapolis-based drugmaker jumped as much as $1.50, or 2.6 percent. Lilly’s stock price has risen about 13 percent this year. Lilly enjoyed strong growth by its antidepressant Cymbalta and its Cialis impotence treatment. Also, two […]
Charges from two acquisitions caused second-quarter profits at Eli Lilly and Co. to slip. Excluding those expenses and other adjustments, Lilly’s profit zoomed past Wall Street’s estimates. The Indianapolis-based drugmaker earned 90 cents per share, excluding unusual items. Analysts expected 82 cents per share, according to a survey by Thomson Financial. Lilly earned 76 cents […]
Indianapolis-based Eli Lilly and Co. and other multinational companies are socking away profits in overseas tax shelters and ultimately stripping the U.S. Treasury of about $50 billion annually, according to The New York Times. Last year, Lilly paid only 6 percent of its $3.4 billion in global profits in taxes, the newspaper said. That’s a […]
Five leaders of Indiana’s life sciences industry offered their perspectives at the Indiana Convention Center June 26 as part of the Indianapolis Business Journal’s Power Breakfast Series. The panelists: Mike Arpey, managing director of global investment bank Credit Suisse’s Asset Management Division and manager of the $73 million Indiana Future Fund for BioCrossroads, the state’s life sciences economicdevelopment initiative. Ron Ellis, co-founder, president and CEO of Lafayettebased Endocyte Inc., a biotechnology company focused on the treatment of cancer through receptor-targeted…
After years of designing banks, churches and condo conversions, Prince/Alexander Architects Inc. is working
with unnamed partners on a plan to replace its headquarters with a $47 million, 24-story hotel and condo development called
West Merrill Tower.
A startup firm using Indiana University medical research to treat a fatal lung disease is raising money for clinical trials and has recruited a prominent life sciences veteran to lead the effort. Michael Klemsz, an associate professor at the IU School of Medicine, and Dr. David Wilkes, director of the school’s Center for Immunobiology, founded Immune Works LLC in January 2006 along with Ronald Meeusen. Meeusen, a former Dow-AgroSciences researcher and BioCrossroads executive, served as a part-time president and CEO…
An idea fermenting for some time in the minds of several Indiana Health Industry Forum insiders has solidified into a plan to catalogue all life sciences-related resources across the state. The not-for-profit group, which promotes economic development in the health care and life sciences industries, will use the information to create strategies for communities, regions and the state to boost Indiana’s growth in the industry. Companies including Eli Lilly and Co., Roche Diagnostics and Zimmer Holdings have put the state…
Eli Lilly and Co. may have found a new use for its osteoporosis drug Evista, according to Bloomberg. The U.S. Food and Drug Administration said Evista reduced the risk of certain invasive breast cancers in post-menopausal women. However, studies from Indianapolis-based Lilly provided weaker support for Evista’s ability to help women at high risk of […]
A major construction project is like a football game-no matter how careful everyone is, sooner or later someone is going to get hurt, at least a little. Indianapolis-based Methodist Occupational Health Centers Inc., which is part of Clarian Health Partners, is partnering with Decatur County Memorial Hospital to provide an answer to this problem at the Honda automobile plant construction site in Greensburg. The two institutions are providing on-site medical services and offsite treatment facilities for workers at the $550…
A significant Indianapolis sporting event with international appeal is preparing to celebrate its 100th anniversary in 2011. The Indianapolis 500? Well, yes, that too. Far less-wellknown and recognized is that the origins of elite-level competitive tennis in Indianapolis also date back to just after the turn of the century … the last century, that is. Records show that the Western Tennis Championships, which led to the U.S. Clay Court Championships, which led to the U.S. Hardcourt Tennis Championships, which led…
